Cargando…

Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial

BACKGROUND: Melanoma is the most lethal form of skin cancer in humans. Conventional therapies have limited efficacy, and overall response is still unsatisfactory considering that immune checkpoint inhibitors induce lasting clinical responses only in a low percentage of patients. This has prompted us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riccardo, Federica, Tarone, Lidia, Camerino, Mariateresa, Giacobino, Davide, Iussich, Selina, Barutello, Giuseppina, Arigoni, Maddalena, Conti, Laura, Bolli, Elisabetta, Quaglino, Elena, Merighi, Irene Fiore, Morello, Emanuela, Dentini, Alfredo, Ferrone, Soldano, Buracco, Paolo, Cavallo, Federica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Clinical/Translational Cancer Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114861/ https://www.ncbi.nlm.nih.gov/pubmed/35580930 http://dx.doi.org/10.1136/jitc-2021-004007

Ejemplares similares

Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma
por: Riccardo, Federica, et al.
Publicado: (2019)

CSPG4: a prototype oncoantigen for translational immunotherapy studies
por: Rolih, Valeria, et al.
Publicado: (2017)

Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retrospective study on 155 cases
por: Giacobino, Davide, et al.
Publicado: (2021)

Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)
por: Camerino, Mariateresa, et al.
Publicado: (2021)

Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research
por: Tarone, Lidia, et al.
Publicado: (2022)

Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs’ Revolution for Immunotherapy
por: Barutello, Giuseppina, et al.
Publicado: (2018)

Improving Osteosarcoma Treatment: Comparative Oncology in Action
por: Tarone, Lidia, et al.
Publicado: (2022)

Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy
por: Peppino, Giulia, et al.
Publicado: (2022)

Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas
por: Riccardo, Federica, et al.
Publicado: (2020)

Prognostic Value of Ki67 and Other Clinical and Histopathological Factors in Canine Apocrine Gland Anal Sac Adenocarcinoma
por: Morello, Emanuela Maria, et al.
Publicado: (2021)

Antitumor immunization of mothers delays tumor development in cancer-prone offspring
por: Barutello, Giuseppina, et al.
Publicado: (2015)

Benign or Low-Grade Malignant Masses Occupying the Pelvic Canal Space in 11 Dogs
por: Ferraris, Erica Ilaria, et al.
Publicado: (2021)

Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy
por: Peppino, Giulia, et al.
Publicado: (2021)

Chondroitin Sulfate Proteoglycan-4 (CSPG4)-Specific Monoclonal Antibody 225.28 in Detection of Acute Myeloid Leukemia Blasts
por: Fenton, Moon, et al.
Publicado: (2015)

Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer
por: Ruiu, Roberto, et al.
Publicado: (2021)

Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis
por: Macagno, Marco, et al.
Publicado: (2022)

Angiomotin like-1 is a novel component of the N-cadherin complex affecting endothelial/pericyte interaction in normal and tumor angiogenesis
por: Zheng, Yujuan, et al.
Publicado: (2016)

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice
por: Bandini, Silvio, et al.
Publicado: (2013)

VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen
por: Nounamo, Bernice, et al.
Publicado: (2023)

A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model
por: Msaki, Aichi, et al.
Publicado: (2016)

Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer
por: Wilkins, Anna, et al.
Publicado: (2021)

A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors
por: Arigoni, Maddalena, et al.
Publicado: (2012)

Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota
por: Di Lorenzo, Antonino, et al.
Publicado: (2020)

Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine
por: Gola, Cecilia, et al.
Publicado: (2021)

The mitotic regulator polo‐like kinase 1 as a potential therapeutic target for c‐Myc‐overexpressing canine osteosarcomas
por: Gola, Cecilia, et al.
Publicado: (2022)

Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models
por: Barutello, Giuseppina, et al.
Publicado: (2022)

Investigating a Prognostic Factor for Canine Hepatocellular Carcinoma: Analysis of Different Histological Grading Systems and the Role of PIVKA-II
por: Maniscalco, Lorella, et al.
Publicado: (2022)

Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy
por: Di Lorenzo, Antonino, et al.
Publicado: (2022)

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo
por: Bolli, Elisabetta, et al.
Publicado: (2017)

Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells
por: Cooney, Craig A, et al.
Publicado: (2011)

The regulatory mechanisms of NG2/CSPG4 expression
por: Ampofo, Emmanuel, et al.
Publicado: (2017)

Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns
por: Riccardo, Federica, et al.
Publicado: (2017)

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers
por: Riccardo, Federica, et al.
Publicado: (2014)

Surgical Excision of Intramuscular Sarcomas: Description of Three Cases in Dogs
por: Olimpo, Matteo, et al.
Publicado: (2023)

An (89)Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor
por: Mason, Christian A., et al.
Publicado: (2020)

IMMU-03. UPDATES ON BRAINCHILD-01, -02, AND -03: PHASE 1 LOCOREGIONAL CAR T CELL TRIALS TARGETING HER2, EGFR, AND B7-H3 FOR CHILDREN WITH RECURRENT CNS TUMORS AND DIPG
por: Vitanza, Nicholas, et al.
Publicado: (2020)

IMMU-10. INTERIM ANALYSIS OF THE HIT-HGG REZ IMMUNVAC STUDY - DENDRITIC CELL VACCINATION WITH PARTIAL TREG DEPLETION IN CHILDREN, ADOLESCENTS, AND ADULTS WITH RELAPSED HIGH-GRADE GLIOMAS
por: Eyrich, Matthias, et al.
Publicado: (2020)

IMMU-19. HDAC INHIBITORS SENSITIZE MYC-AMPLIFIED MEDULLOBLASTOMA TO IMMUNOTHERAPY BY ACTIVATING THE NF-kB PATHWAYS
por: Marquardt, Viktoria, et al.
Publicado: (2020)

IMMU-05. B7-H3-SPECIFIC CAR T CELLS HAVE POTENT ANTI-TUMOR ACTIVITY IN THE GL261 IMMUNE-COMPETENT MURINE BRAIN TUMOR MODEL
por: Haydar, Dalia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8uupnhjclh4fp0b7lvlud7qst0